Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS EXPLAINER

What the Moderna–NIH COVID vaccine patent fight means for research

Collaborators are locked in a high-stakes dispute over which researchers should be named as inventors on a key vaccine patent application.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

It was a testament to the power of collaboration: scientists at the biotechnology firm Moderna Therapeutics teamed up with government researchers at the US National Institutes of Health (NIH) to swiftly produce one of the world’s first successful COVID-19 vaccines.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 600, 200-201 (2021)

doi: https://doi.org/10.1038/d41586-021-03535-x

References

  1. Pallesen, J. et al. Proc. Natl Acad. Sci. USA 114, E7348–e7357 (2017).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links